Nora Therapeutics News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Nora therapeutics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Nora Therapeutics Today - Breaking & Trending Today

Evelo Biosciences Announces Appointments of Luca Scavo as Chief Financial Officer and Julie H. McHugh to the Board of Directors

Evelo Biosciences Announces Appointments of Luca Scavo as Chief Financial Officer and Julie H. McHugh to the Board of Directors
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United Kingdom , New Jersey , United States , Julieh Mchugh , Roche Latin America , Luca Scavoluca Scavo , Universita Politecnica Delle Marche , Evelo Biosciencesevelo Biosciences , Evelo Biosciences Inc , Boards Of Xellia Pharmaceuticals , Board Of Directors At Ironwood Pharmaceuticals , Pennsylvania State University , Endo Health Solutions , Joseph University , Business Administration , Company Group , Aerie Pharmaceuticals , Luca Scavo , Chief Financial Officer , Senior Vice President , Roche Diagnostics North , Nora Therapeutics , Simba Gill , Chief Executive Officer , Vice President , Chief Accounting Officer ,

Evelo Biosciences, Inc.: Evelo Biosciences Announces Appointments of Luca Scavo as Chief Financial Officer and Julie H. McHugh to the Board of Directors

(0)
CAMBRIDGE, Mass., April 15, 2021 (GLOBE NEWSWIRE) Evelo Biosciences, Inc. (Nasdaq:EVLO), a clinical stage biotechnology company developing a new modality of orally delivered medicines, today announced the appointments of Luca Scavo as Chief Financial Officer (CFO), effective June 1, 2021, and Julie H. McHugh to its Board of Directors, effective immediately.
Mr. Scavo brings more than 25 years of international experience in both emerging and developed markets within pioneering biotechnology and diagnostics companies including Genentech, Roche and AstraZeneca, where he led teams across diverse global markets and through different stages of a company s life cycle. He most recently served as Senior Vice President and CFO of Roche Diagnostics North America. ....

United Kingdom , New Jersey , United States , Evelo Biosciences , Jessica Cotrone , Julieh Mchugh , Roche Latin America , Kostenloser Wertpapierhandel , Universita Politecnica Delle Marche , Luca Scavo , Evelo Biosciences Inc , Boards Of Xellia Pharmaceuticals , Board Of Directors At Ironwood Pharmaceuticals , Pennsylvania State University , Endo Health Solutions , Joseph University , Business Administration , Company Group , Aerie Pharmaceuticals , Chief Financial Officer , Senior Vice President , Roche Diagnostics North , Nora Therapeutics , Simba Gill , Chief Executive Officer , Vice President ,

Evelo Biosciences Announces Appointments of Luca Scavo as Chief Financial Officer and Julie H. McHugh to the Board of Directors

Evelo Biosciences Announces Appointments of Luca Scavo as Chief Financial Officer and Julie H. McHugh to the Board of Directors
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United Kingdom , New Jersey , United States , Evelo Biosciences , Julieh Mchugh , Roche Latin America , Universita Politecnica Delle Marche , Luca Scavo , Evelo Biosciences Inc , Boards Of Xellia Pharmaceuticals , Board Of Directors At Ironwood Pharmaceuticals , Pennsylvania State University , Endo Health Solutions , Joseph University , Business Administration , Company Group , Aerie Pharmaceuticals , Wall Street , Chief Financial Officer , Senior Vice President , Roche Diagnostics North , Nora Therapeutics , Simba Gill , Chief Executive Officer , Vice President , Chief Accounting Officer ,

Ironwood Pharmaceuticals Announces CEO Transition

Published: Feb 08, 2021

– Julie McHugh to become Executive Chair of the Board of Directors –

BOSTON (BUSINESS WIRE) Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD), a GI-focused healthcare company, today announced that Mark Mallon plans to step down as chief executive officer and a member of the Ironwood Board of Directors in order to pursue another leadership opportunity, effective March 12, 2021. The Ironwood Board has named Thomas McCourt, Ironwood’s president, as interim CEO effective upon Mr. Mallon’s departure. Julie McHugh, Ironwood’s Board chair, will become executive chair of the Board of Directors effective upon Mr. Mallon’s departure and, in that capacity, will continue to lead the Board of Directors as well as provide counsel and guidance to the senior management team through the transition. ....

New England Institute , United States , Pennsylvania State University , Mark Mallon , Thomas Mccourt , Tom Mccourt , Julie Mchugh , Ironwood Pharmaceuticals Nasdaq , Ironwood Pharmaceuticals Inc , Trevena Inc , Ironwood Pharmaceuticals , Centocor Inc , Pennsylvania Biotechnology Association , Astra Merck Inc , Nora Therapeutics Inc , Endo Health Solutions Inc , American Society Of Gastrointestinal Endoscopy , Xellia Group , Aerie Pharmaceuticals Inc , England Healthcare Institute , Viropharma Inc , Biotechnology Industry Organization , University Of Wisconsin , Epirus Biopharmaceuticals Inc , Joseph University , Amgen Inc ,